eosinophilic endomyocardial disease

FREE subscriptions for doctors and students... click here
You have 3 more open access pages.

Eosinophilic endomyocardial disease is characterized by:

  • endomyocardial fibrosis
  • a high incidence at temperate latitudes
  • large mural thrombi
  • eosinophilia with infiltration of organs especially the heart (causing restrictive cardiomyopathy)
  • rapid fatality

This disease is closely related to the African condition of endomyocardial fibrosis (qv).

Treatment measures include:

  • suppression of eosinophilia e.g. prednisolone or hydroxycarbamide (former British Approved Name, hydroxyurea)
  • digoxin
  • diuretics

Last reviewed 01/2018

Links: